Showing results (1941-1950 of 2,436) with videos related to

Sort By:
Pageof 244
Nature Communications|January 24, 2025
Specific types of male infertility are correlated with T cell exhaustion or senescence signaturesGiada Amodio, Giorgia Giacomini, Luca Boeri, et al.
Frontiers in Pharmacology|June 12, 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cellsPaola Pacelli, Adele Santoni, Anna Sicuranza, et al.
Journal of Neurology|July 10, 2026
Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 studyMassimo Filippi, Luigi M E Grimaldi, Vincenzo Brescia Morra, et al.
Journal of Extracellular Vesicles|January 1, 2022
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA: Dual role in cancer immunosurveillanceElisabetta Vulpis, Luisa Loconte, Agnese Peri, et al.
Cancer Research|April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastomaHeidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Molecular & Cellular Proteomics : MCP|June 1, 2013
The human PDZome: a gateway to PSD95-Disc large-zonula occludens (PDZ)-mediated functionsEdwige Belotti, Jolanta Polanowska, Avais M Daulat, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 30, 2020
Pathogenic mosaic variants in congenital hypogonadotropic hypogonadismJames S Acierno, Cheng Xu, Georgios E Papadakis, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 30, 2020
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre studyGiovanni Peretto, Andrea Barison, Cinzia Forleo, et al.
Anti-Cancer Drugs|December 20, 2022
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinomaSebastiano Buti, Chiara Tommasi, Giulia Scartabellati, et al.
Diagnostics (Basel, Switzerland)|January 22, 2021
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?Matteo Santoni, Francesco Massari, Sergio Bracarda, et al.
Pageof 244